Ascendis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
12.96B
Market cap12.96B
Price-Earnings ratio
-50.21
Price-Earnings ratio-50.21
Dividend yield
Dividend yield
Average volume
894.37K
Average volume894.37K
High today
$212.56
High today$212.56
Low today
$204.52
Low today$204.52
Open price
$210.32
Open price$210.32
Volume
612.50K
Volume612.50K
52 Week high
$229.94
52 Week high$229.94
52 Week low
$118.03
52 Week low$118.03

Stock Snapshot

With a market cap of 12.96B, Ascendis Pharma(ASND) trades at $212.11. The stock has a price-to-earnings ratio of -50.21.

As of 2025-12-16, Ascendis Pharma(ASND) stock has fluctuated between $204.52 and $212.56. The current price stands at $212.11, placing the stock +3.7% above today's low and -0.2% off the high.

Ascendis Pharma(ASND) shares are trading with a volume of 612.5K, against a daily average of 894.37K.

During the past year, Ascendis Pharma(ASND) stock moved between $118.03 at its lowest and $229.94 at its peak.

During the past year, Ascendis Pharma(ASND) stock moved between $118.03 at its lowest and $229.94 at its peak.

ASND News

Simply Wall St 2d
Can Ascendis Pharma Still Offer Value After 2025 Rally and Endocrinology Milestones?

If you are wondering whether Ascendis Pharma at around $220 a share is still good value after such a strong run, you are not alone. That is exactly what this br...

Can Ascendis Pharma Still Offer Value After 2025 Rally and Endocrinology Milestones?
TipRanks 4d
Ascendis Pharma rumor highlighted in Betaville blog

A rumor regarding Ascendis Pharma (ASND) was highlighted in Ben Harrington’s M&A-focused Betaville blog, contacts tell The Fly. Claim 50% Off TipRanks Premium...

Nasdaq 4d
March 2026 Options Now Available For Ascendis Pharma

Investors in Ascendis Pharma A/S (Symbol: ASND) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into th...

March 2026 Options Now Available For Ascendis Pharma

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.